Elsevier

Clinical Biochemistry

Volume 26, Issue 4, August 1993, Pages 231-240
Clinical Biochemistry

Troponin-T and CK MB (Mass) in early diagnosis of ischemic myocardial injury. The Helsingborg study, 1992

https://doi.org/10.1016/0009-9120(93)90122-MGet rights and content

Abstract

We evaluated cardiac troponin T (S-troponin T) versus CK MB in serum (S-CK MB) sampled 4, 10, 16, and 22 h after onset of acute symptoms in 207 consecutive cases admitted to our coronary care unit in Helsingborg, Sweden, May–October 1992. These were primarily classified into 106 acute myocardial infarctions (AMI) and 101 NOT-AMI cases by conventional cardiological criteria plus S-CK MB (mass). Time curves of S-troponin T and S-CK MB data were plotted for each individual case. Twelve of the 101 cases in the NOT-AMI group showed increased S-troponin T indicating ischemic myocardial injuries. The same cases also showed changes of S-CK MB (mass), though below its discriminator. Seven of these cases were reclassified as minor myocardial damage, constituting 25% of our 28 cases of unstable angina. The remaining five cases showed a combination of constantly increased S-troponin T and decreasing or low S-CK MB mass values as seen after a recent infarction. Consequently, the patient material was reclassified into 118 cases of ischemic myocardial injury (106 conventional AMI + 7 minor myocardial damage + 5 postinfarctions) and 89 cases of NOT-ischemic myocardial injury.

The frequency distributions of the maximal S-troponin T and S-CK MB (mass) values of each case were plotted in double test evaluation histograms. For troponin T, discriminator 0.20 μg/L, clinical sensitivity for ischemic myocardial injury was 97% and specificity 99%. With a lower discriminator of 0.10 μg/L, sensitivity increased to 99% and specificity decreased to 89%. For S-CK MB (mass), discriminator 10 μg/L, sensitivity was 91%, specificity 98%. With a lower discriminator of 5 μg/L sensitivity increased to 96% and specificity decreased to 78%. We conclude that as a single routine test, S-troponin T is the marker of choice for early diagnosis of ischemic myocardial damage. The combination S-troponin T and S-CK MB (mass) provides additional, detailed information in reinforction and postinfarction unstable angina pectoris.

References (27)

  • W. Gerhardt et al.

    Rational diagnostic strategy in diagnosis of myocardial infarction. S-troponin T and S-CK MB (mass) time series using individual baseline values

    Scand J Clin Lab Invest

    (1993)
  • Ravkilde J, Hørder M, Gerhardt W, Ljungdahl L, et al. Risk stratification in suspected acute myocardial infarction...
  • W. Gerhardt et al.

    S-troponin T as a marker of ischemic myocardial injury

    Clin Chem

    (1992)
  • Cited by (77)

    • Ginseng total saponin attenuates myocardial injury via anti-oxidative and anti-inflammatory properties

      2015, Journal of Ginseng Research
      Citation Excerpt :

      The coronary effluent was collected after reperfusion. Myocardial injury was assessed using the LDH level [17], CK-MB activity [18], and cTnI level [19]. Evidence of oxidative stress was evaluated from left ventricle tissue using MDA and GSH analyses.

    • Cardiac biomarkers in acute myocardial infarction

      2013, International Journal of Cardiology
      Citation Excerpt :

      cTn was proposed as a specific marker of myocardial necrosis but the high sensitivity of cTn compared with CK and CKMB had not been envisaged. Early studies showed that cTn was raised in AMI (as diagnosed by WHO criteria) [7,20–27] with high sensitivities and specificities [7,12,17,22,24,25,28–38] and had the advantage over CKMB in differentiating cardiac from skeletal muscle injury [7,39]. Studies in the 1990s also showed that significant numbers of patients classed as unstable angina (as opposed to AMI) by conventional WHO criteria, had elevated cTn levels [25,26,36,38–44].

    • Cardiac Troponins: Clinical and Analytical Aspects

      2006, Advances in Clinical Chemistry
      Citation Excerpt :

      Early detection of these patients would afford the opportunity to intervene early with improved mortality (refer to Jesse and Kukreja [89]). Regarding reinfarction, CK‐MB due to its rapid rate of rise and fall is used [90, 91, 92], although it has been shown that cTnT with its biphasic release pattern has equal, if not better, clinical utility [83, 93]. Myoglobin, which has the shortest half‐life in circulation, has been suggested to be the best marker of a reinfarction [94, 95], although others have refuted this claim [82, 96].

    • Cardiac troponins

      2002, Journal of Emergency Medicine
    View all citing articles on Scopus
    View full text